These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1314066)

  • 41. Manipulation of the bluetongue virus tubules for immunogen delivery.
    Murphy A; Roy P
    Future Microbiol; 2008 Jun; 3(3):351-9. PubMed ID: 18505400
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Functional dissection of the major structural protein of bluetongue virus: identification of key residues within VP7 essential for capsid assembly.
    Limn CK; Staeuber N; Monastyrskaya K; Gouet P; Roy P
    J Virol; 2000 Sep; 74(18):8658-69. PubMed ID: 10954567
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Microspheres-prime/rMVA-boost vaccination enhances humoral and cellular immune response in IFNAR(-/-) mice conferring protection against serotypes 1 and 4 of bluetongue virus.
    Marín-López A; Calvo-Pinilla E; Barriales D; Lorenzo G; Benavente J; Brun A; Martínez-Costas JM; Ortego J
    Antiviral Res; 2017 Jun; 142():55-62. PubMed ID: 28322923
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assembly of five bluetongue virus proteins expressed by recombinant baculoviruses: inclusion of the largest protein VP1 in the core and virus-like proteins.
    Loudon PT; Roy P
    Virology; 1991 Feb; 180(2):798-802. PubMed ID: 1846500
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An atomic model of the outer layer of the bluetongue virus core derived from X-ray crystallography and electron cryomicroscopy.
    Grimes JM; Jakana J; Ghosh M; Basak AK; Roy P; Chiu W; Stuart DI; Prasad BV
    Structure; 1997 Jul; 5(7):885-93. PubMed ID: 9261080
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The pathogenesis of bluetongue virus infection of bovine blood cells in vitro: ultrastructural characterization.
    Brewer AW; MacLachlan NJ
    Arch Virol; 1994; 136(3-4):287-98. PubMed ID: 8031234
    [TBL] [Abstract][Full Text] [Related]  

  • 47. RGD tripeptide of bluetongue virus VP7 protein is responsible for core attachment to Culicoides cells.
    Tan BH; Nason E; Staeuber N; Jiang W; Monastryrskaya K; Roy P
    J Virol; 2001 Apr; 75(8):3937-47. PubMed ID: 11264382
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Protective efficacy of Bluetongue virus-like and subvirus-like particles in sheep: presence of the serotype-specific VP2, independent of its geographic lineage, is essential for protection.
    Stewart M; Dovas CI; Chatzinasiou E; Athmaram TN; Papanastassopoulou M; Papadopoulos O; Roy P
    Vaccine; 2012 Mar; 30(12):2131-9. PubMed ID: 22285887
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A characterization of the nonstructural protein from which the virus-specified tubules in epizootic haemorrhagic disease virus-infected cells are composed.
    Nel LH; Picard LA; Huismans H
    Virus Res; 1991 Mar; 18(2-3):219-30. PubMed ID: 1645906
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nucleotide sequence of the genome segment encoding nonstructural protein NS1 of bluetongue virus serotype 20 from Australia.
    Cowley JA
    Virus Genes; 1992 Nov; 6(4):387-92. PubMed ID: 1335630
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis of the virus-specified tubules of epizootic haemorrhagic disease virus using a baculovirus expression system.
    Nel LH; Huismans H
    Virus Res; 1991 May; 19(2-3):139-52. PubMed ID: 1891959
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of the non-structural protein, NS1, of tick-borne and insect-borne orbiviruses.
    Moss SR; Nuttall PA
    Virus Res; 1995 May; 36(2-3):287-92. PubMed ID: 7653106
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nucleotide and deduced amino acid sequence of the nonstructural protein, NS1, of the US bluetongue virus serotype 17.
    Grubman MJ; Samal S
    Nucleic Acids Res; 1989 Dec; 17(24):10498. PubMed ID: 2557592
    [No Abstract]   [Full Text] [Related]  

  • 54. Interaction between a Unique Minor Protein and a Major Capsid Protein of Bluetongue Virus Controls Virus Infectivity.
    Matsuo E; Yamazaki K; Tsuruta H; Roy P
    J Virol; 2018 Feb; 92(3):. PubMed ID: 29142128
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Uncoating of parental bluetongue virus to core and subcore particles in infected L cells.
    Huismans H; van Dijk AA; Els HJ
    Virology; 1987 Mar; 157(1):180-8. PubMed ID: 3029957
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetically engineered multi-component virus-like particles as veterinary vaccines.
    Pearson LD; Roy P
    Immunol Cell Biol; 1993 Oct; 71 ( Pt 5)():381-9. PubMed ID: 8270267
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Courageous science: structural studies of bluetongue virus core.
    Rossmann MG; Tao Y
    Structure; 1999 Mar; 7(3):R43-6. PubMed ID: 10368304
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interactions between bluetongue virus core and capsid proteins translated in vitro.
    Liu HM; Booth TF; Roy P
    J Gen Virol; 1992 Oct; 73 ( Pt 10)():2577-84. PubMed ID: 1328473
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Strong protection induced by an experimental DIVA subunit vaccine against bluetongue virus serotype 8 in cattle.
    Anderson J; Hägglund S; Bréard E; Riou M; Zohari S; Comtet L; Olofson AS; Gélineau R; Martin G; Elvander M; Blomqvist G; Zientara S; Valarcher JF
    Vaccine; 2014 Nov; 32(49):6614-21. PubMed ID: 25312275
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative effects of bluetongue virus infection of ovine and bovine endothelial cells.
    Russell H; O'Toole DT; Bardsley K; Davis WC; Ellis JA
    Vet Pathol; 1996 May; 33(3):319-31. PubMed ID: 8740706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.